PMID- 29308277
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220311
IS  - 2147-9720 (Print)
IS  - 2148-4279 (Electronic)
IS  - 2147-9720 (Linking)
VI  - 4
IP  - 4
DP  - 2017 Dec
TI  - Fibromyalgia has a high prevalence and impact in cardiac failure patients.
PG  - 245-249
LID - 10.5152/eurjrheum.2017.17026 [doi]
AB  - OBJECTIVE: Chronic cardiac failure (CCF) shares several clinical features with 
      fibromyalgia (FM), a syndrome of increased central sensitivity and 
      musculoskeletal pain. FM frequently coexists with other chronic illness. 
      Musculoskeletal pain is reported in patients with CCF; however, the prevalence 
      and impact of FM in patients with CCF is not known. This research aims to assess 
      the prevalence and effects of concurrent FM in patients with CCF and to identify 
      other coexisting central sensitivity syndromes. MATERIAL AND METHODS: In a 
      cross-sectional study, demographic, clinical, and functional information was 
      gathered from participants with CCF from public and private clinics. Cardiac 
      failure severity was rated using the New York Heart Association (NYHA) scale. FM 
      diagnosis was determined using 2011 American College of Rheumatology (ACR) 
      criteria. The short-form 36 (SF-36) assessed overall health function. RESULTS: Of 
      the 57 CCF participants (63.2% male, mean age 70.3 years), 22.8% (n=13) met FM 
      diagnostic criteria. CCF patients with FM had poorer outcomes across multiple 
      SF-36 domains (p<0.05), compared to those without, despite having comparable CCF 
      severity. Those with FM were more likely to report other central sensitivity 
      syndromes, especially temporomandibular joint dysfunction (mean Delta=23%, p<0.05), 
      headache (mean Delta=28.8%, p<0.05), and irritable bladder (mean Delta=14%, p<0.05). 
      CONCLUSION: High prevalence of FM was found in patients with CCF. This was 
      associated with increased likelihood of other comorbid central sensitivity 
      syndromes and with poorer clinical outcomes. The recognition of coexisting FM in 
      patients with CCF provides an important opportunity to improve health outcomes by 
      managing FM-related symptoms, in addition to symptoms that relate specifically to 
      CCF.
FAU - Gist, Anthea C
AU  - Gist AC
AD  - Monash University School of Medicine, Victoria, Australia.
FAU - Guymer, Emma K
AU  - Guymer EK
AD  - Monash University School of Medicine, Victoria, Australia.
FAU - Ajani, Andrew E
AU  - Ajani AE
AD  - Monash University School of Medicine, Victoria, Australia.
AD  - University of Melbourne School of Medicine, Victoria, Australia.
FAU - Littlejohn, Geoffrey O
AU  - Littlejohn GO
AD  - Monash University School of Medicine, Victoria, Australia.
LA  - eng
PT  - Journal Article
DEP - 20171102
PL  - Turkey
TA  - Eur J Rheumatol
JT  - European journal of rheumatology
JID - 101656068
PMC - PMC5741335
OTO - NOTNLM
OT  - Cardiac failure
OT  - chronic pain
OT  - fibromyalgia
OT  - prevalence
COIS- Conflict of Interest: The authors declared no conflict of interest.
EDAT- 2018/01/09 06:00
MHDA- 2018/01/09 06:01
PMCR- 2017/12/01
CRDT- 2018/01/09 06:00
PHST- 2017/03/23 00:00 [received]
PHST- 2017/06/09 00:00 [accepted]
PHST- 2018/01/09 06:00 [entrez]
PHST- 2018/01/09 06:00 [pubmed]
PHST- 2018/01/09 06:01 [medline]
PHST- 2017/12/01 00:00 [pmc-release]
AID - ejr-4-4-245 [pii]
AID - 10.5152/eurjrheum.2017.17026 [doi]
PST - ppublish
SO  - Eur J Rheumatol. 2017 Dec;4(4):245-249. doi: 10.5152/eurjrheum.2017.17026. Epub 
      2017 Nov 2.